Type 1 Versus Type 2 Cytokine Release by Vβ T Cell Subpopulations Determines in Vivo Antitumor Reactivity: IL-10 Mediates a Suppressive Role

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 664-673

  Aruga, Atsushi ^a,b   Aruga, Etsuko ^a,c   Tanigawa, Keishi ^a   Bishop, D Keith ^a   Sondak, Vernon K ^a   Chang, Alfred E ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CYTOTOXICITY; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; MOUSE; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN VARIABLE REGION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 0031570931     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
2. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279.
3. Croft, M., L. Carter, S. L. Swain, and R. W. Dutton. 1994. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1715.
4. + cells can switch to interleukin 5 production and induce airway eosinophilia. J. Exp. Med. 181:1229.
5. Yoshizawa, H., K. Sakai, A. E. Chang, and S. Shu. 1991. Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapy. Cell. Immunol. 134:473.
6. Yoshizawa, H., A. E. Chang, and S. Shu. 1991. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. J. Immunol. 147:729.
7. Yoshizawa, H., A. E. Chang, and S. Shu. 1992. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells. Cancer Res. 52:1129.
8. Barth, R. J., S. N. Bock, J. J. Mulé, and S. A. Rosenberg. 1990. Unique murine tumor-associated antigens identified by tumor infiltration lymphocytes. J. Immunol. 144:1531.
9. Oberdan, L., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84:1374.
10. Shu, S., R. A. Krinock, T. Matsumura, J. J. Sussman, B. A. Fox, A. E. Chang, and D. S. Terman. 1994. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. J. Immunol. 152:1277.
11. Wexler, H. 1966. Accurate identification of experimental pulmonary metastases. J. Natl. Cancer Inst. 36:641.
12. + tumor-draining lymph node cells involved in mediating tumor regression. J. Leukocyte Biol. 61:507.
13. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281.
14. Spiess, P. J., J. C. Yang, and S. A. Rosenberg. 1987. In vivo antitumor activity of tumor-infiltration lymphocytes expanded in recombinant interleukin-2. J. Natl. Cancer Inst. 79:1067.
15. + tumor infiltrating lymphocytes. J. Exp. Med. 171:647.
16. Ohno, K., H. Yoshizawa, H. Tsukada, T. Takeda, Y. Yamaguchi, K. Ichikawa, Y. Maruyama, Y. Suzuki, E. Suzuki, and M. Arakawa. 1996. Adoptive immunotherapy with tumor-specific T lymphocytes generated from cytokine gene-modified tumor-primed lymph node cells. J. Immunol. 156:3875.
17. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulation their development. Immunol. Rev. 123:115.
18. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
19. Hsieh, C.-S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
20. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1652.
21. Windhagen A., D. E. Anderson, A. Carrizosa, R. E. Williams, and D. A. Hafler. 1996. IL-12 induces human T cells secreting IL-10 with IFN-γ. J. Immunol. 157:1127.
22. Kleinerman, E. S., R. D. Knowles, L. B. Lachman, and J. U. Gutterman. 1988. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res. 48:2604.
23. Tuttle, T. M., C. W. McCrady, T. H. Inge, M. Salour, and H. D. Bear. 1993. γ-Interferon plays a key role in T cell induced tumor regression. Cancer Res. 53:833.
24. Shu, S., L. S. Fonseca, H. Kato, and B. Zbar. 1983. Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity. Cancer Res. 43::2637.
25. Mulé, J. J., M. Rosenstein, S. Shu, and S. A. Rosenberg. 1985. Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s). Cancer Res. 45:526.
26. Weber, J. S., G. Jay, K. Tanaka, and S. A. Rosenberg. 1987. Immunotherapy of a murine tumor with interleukin-2: increased sensitivity after MHC class I gene transfection. J. Exp. Med. 166:1716.
27. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulation factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
28. Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317.
29. Nestle, F. O., G. Burg, J. Fah, and B. J. Nickoloff. 1997. In vivo and in vitro characterization of human tumor associated dendritic cells: deficiency in T cell co-stimulatory molecules and impaired antigen-presenting function. Am. J. Pathol. In press.
30. Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff, and K. Uyemura. 1995. IL-10 production in cutaneous basal and squamous cell carcinomas. J. Immunol. 155:2240.